Abstract
Background
Metabolic syndrome (MS) is common among morbidly obese patients undergoing bariatric surgery. The aim of this study was to assess the impact and predictors of bariatric surgery on the resolution of MS.
Methods
Subjects included 286 patients [age 44.0 ± 11.5, female 78.2%, BMI 48.7 ± 9.4, waist circumference 139 ± 20 cm, AST 23.5 ± 14.9, ALT 30.0 ± 20.1, type 2 diabetes mellitus (DM) 30.1% and MS 39.2%] who underwent bariatric surgery.
Results
Of the entire cohort, 27.3% underwent malabsorptive surgery, 55.9% underwent restrictive surgery, and 16.8% had combination restrictive–malabsorptive surgery. Mean weight loss was 33.7 ± 20.1 kg after restrictive surgery (follow up period 298 ± 271 days), 39.4 ± 22.9 kg after malabsorptive surgery (follow-up period 306 ± 290 days), and 28.3 ± 14.1 kg after combination surgery (follow-up period 281 ± 239 days). Regardless of the type of bariatric surgery, significant improvements were noted in MS (p values from <0.0001–0.01) as well as its components such as DM (p values from <0.0001–0.0005), waist circumference (p values <0.0001), BMI (p values <0.0001), fasting serum triglycerides (p values <0.0001 to 0.001), and fasting serum glucose (p values <0.0001). Additionally, a significant improvement in AST/ALT ratio (p value = 0.0002) was noted in those undergoing restrictive surgery. Multivariate analysis showed that patients who underwent malabsorptive bariatric procedures experienced a significantly greater percent excess weight loss than patients who underwent restrictive procedures (p value = 0.0451). Percent excess weight loss increased with longer postoperative follow-up (p value <0.0001).
Conclusions
Weight loss after bariatric surgery is associated with a significant improvement in MS and other metabolic factors.
Similar content being viewed by others
References
Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2006 Feb;35:93–9.
Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;5(295):1549–55.
Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss progams in the United States. Ann Intern Med. 2005;4(142):56–66.
Zhao Y, Encinosa W. Agency for Healthcare Research and Quality AHRQ Bariatric Surgery Utilization and Outcomes in 1998 and 2004. Statistical Brief. #23, 2007.
Ricciardi R, Town RJ, Kellogg TA, Ikramuddin S, Baxter NN. Outcomes after open versus laparoscopic gastric bypass. Surg Laparosc Endosc Percutan Tech. 2006;16:317–20.
Sjostrom L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–52.
Unknown. National Institutes of Health Consensus Development Conference Draft Statement on Gastrointestinal Surgery for Severe Obesity, 25–27 March 1991. Obes Surg. 1991;1(No.3):257–65.
Buchwald H. Consensus Conference Statement. Bariatric surgery for morbid obesity: health implications for patients, health professionals and third party payers. Surg Obes Relat Dis. 2005:371–81.
Madan AK, Orth W, Ternovits CA, Tichansky DS. Metabolic syndrome: yet another co-morbidity gastric bypass helps cure. Surg Obes Relat Dis. 2006;2:48–51.
Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242:610–20.
Alberti KG, Simmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 2002;15:539–53.
Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–89.
Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–50.
Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on the Metabolic syndrome. Arch Surg. 2004;139:1088–92.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Valera-Mora ME, Simeoni B, Gagliardi L, et al. Predictors of weight loss and reversal of co morbidities in malabsorptive bariatric surgery. Am J Clin Nutr. 2005;81:1292–97.
Kinzl JF, Schrattenecker M, Traweger C, Mattesich M, Fiala M, Biebl W. Psychosocial predictors of weight loss after bariatric surgery. Obes Surg. 2006;16:1609–14.
Averbukh Y, Heshka S, El-Shoreya H, et al. Depression score predicts weight loss following gastric bypass. Obes Surg. 2003;13:833–36.
Lutfi R, Torquati A, Sekhar N, Richards WO. Predictors of success after laparoscopic gastric bypass: a multivariate analysis of socioeconomic factors. Surg Endosc. 2006;20:864–67.
Madan AK, Whitfield JD, Fain JN, et al. Are African Americans as successful as Caucasians after laparoscopic gastric bypass? Obes Surg. 2007;17:460–64.
Olbers T, Fagevik-Olsen M, Maleckas A, et al. Randomized clinical trial of laparoscopic Roux-en Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg. 2005;92:557–62.
Mognol P, Chosidow D, Marmuse JP. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Obes Surg. 2005;15:76–81.
Cottam DR, Atkinson J, Anderson A, Grace B, Fisher B. Case controlled matched pair cohort study of lap roux en Y gastric bypass and Lap band patients in a single US center with three year follow up. Obes Surg. 2006;16:534–40.
Bowne WB, Julliard K, Castro AE, Shah P, Morgenthal CB, Ferzli GS. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: a prospective, comparative analysis. Arch Surg. 2006;141:683–89.
Ternovits CA, Tichansky DS, Madan AK. Band versus bypass: randomization and patients' choices and perceptions. Surg Obes Relat Dis. 2006;2:6–10.
Lanyon RI, Maxwell BM. Predictors of outcome after gastric bypass surgery. Obes Surg. 2007;17:321–8.
Perugini RA, Mason R, Czerniach DR, et al. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg. 2003;138:541–45.
Chau WY, Schmidt HJ, Kouli W, Davis D, Wasielewski A, Ballantyne GH. Patient characteristics impacting excess weight loss following laparoscopic adjustable gastric banding. Obes Surg. 2005;15:346–50.
Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.
Skroubis G, Anesidis S, Kehagias I, Mead N, Vagenas K, Kalfarentzos F. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg. 2006;16:488–95.
Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):127–32.
Greenway SE, Greenway FL III, Klein S, et al. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109–17.
Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;24(154):193–200.
Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux en Y gastric bypass. J Am Coll Surg. 2006;203:24–9.
Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric resective operations for morbid obesity. J Gastrointest Surg. 2000;4:464–69.
Frutos MD, Lujan J, Hernandez Q, Valero G, Parrilla P. Results of laparoscopic gastric bypass in patients > or =55 years old. Obes Surg. 2006;16:461–64.
Shawn, et al. Impact of Advanced age of weight loss and health benefits after lap. Gastric bypass. Arch Surg. 2005;140:165–68.
Case CC, Jones PH, Nelson K, O’Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002;4:407–14.
Phelan S, Wadden TA, Berkowitz RI, et al. Impact of weight loss on the metabolic syndrome. Int J Obes. 2007;31:1442–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nugent, C., Bai, C., Elariny, H. et al. Metabolic Syndrome after Laparoscopic Bariatric Surgery. OBES SURG 18, 1278–1286 (2008). https://doi.org/10.1007/s11695-008-9511-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-008-9511-1